Literature DB >> 7801876

Efficacy and safety of digoxin alone and in combination with low-dose diltiazem or betaxolol to control ventricular rate in chronic atrial fibrillation.

K K Koh1, K S Kwon, H B Park, S H Baik, S J Park, K H Lee, E J Kim, S H Kim, S K Cho, S S Kim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7801876     DOI： 10.1016/s0002-9149(99)80538-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  9 in total

1.  Rate control in atrial fibrillation: what approach is best?

Authors:  Brian Olshansky
Journal:  Curr Cardiol Rep       Date:  2004-09       Impact factor: 2.931

Review 2.  When, and when not, to use digoxin in the elderly.

Authors:  A T Gosselink; D J van Veldhuisen; H J Crijns
Journal:  Drugs Aging       Date:  1997-06       Impact factor: 3.923

3.  Rate control in permanent atrial fibrillation.

Authors:  Theodora Nikolaidou; Kevin S Channer
Journal:  BMJ       Date:  2007-11-24

4.  Rate control in atrial fibrillation, insight into the RACE II study.

Authors:  H F Groenveld; H J G M Crijns; J G P Tijssen; M Alings; H L Hillege; Y S Tuininga; M P Van den Berg; D J Van Veldhuisen; I C Van Gelder
Journal:  Neth Heart J       Date:  2013-04       Impact factor: 2.380

5.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

Review 6.  New-onset atrial fibrillation in critically ill patients.

Authors:  Stephanie Sibley; John Muscedere
Journal:  Can Respir J       Date:  2015 May-Jun       Impact factor: 2.409

7.  Digoxin and mortality in atrial fibrillation: a prospective cohort study.

Authors:  Pär Hallberg; Johan Lindbäck; Bertil Lindahl; Ulf Stenestrand; Håkan Melhus
Journal:  Eur J Clin Pharmacol       Date:  2007-08-08       Impact factor: 2.953

Review 8.  Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.

Authors:  Naqash J Sethi; Emil E Nielsen; Sanam Safi; Joshua Feinberg; Christian Gluud; Janus C Jakobsen
Journal:  PLoS One       Date:  2018-03-08       Impact factor: 3.240

9.  A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial.

Authors:  Dipak Kotecha; Melanie Calvert; Jonathan J Deeks; Michael Griffith; Paulus Kirchhof; Gregory Yh Lip; Samir Mehta; Gemma Slinn; Mary Stanbury; Richard P Steeds; Jonathan N Townend
Journal:  BMJ Open       Date:  2017-07-20       Impact factor: 2.692
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.